News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Offering Of Evotec OAI (Germany) (EVTG.F) Shares Successfully Completed


4/27/2006 11:13:38 AM

HAMBURG, Germany and OXFORD, England, April 27 /PRNewswire-FirstCall/ -- Evotec AG announced that today 5,228,701 Evotec shares were successfully placed by DZ BANK AG, Frankfurt, as Sole Lead Manager and Sole Bookrunner. The new shares from a capital increase against contribution in cash from authorised capital were offered to institutional investors in Europe and the US in an accelerated bookbuilding and allocated at a price of EUR 3.55 per share.

Evotec receives gross issue proceeds amounting to EUR 18.5 million. Due to the capital increase, the number of Evotec shares will rise from 62,744,415 to 67,973,116.

Contact:

Evotec AG, Anne Hennecke, Investor Relations, Schnackenburgallee 114, 22525 Hamburg, Germany, Phone: +49-(0)40-56081-286, Fax: +49-(0)40-56081-333, E-mail: investor.relations@evotec.com

Evotec AG

CONTACT: Evotec AG, Anne Hennecke, Investor Relations, Schnackenburgallee114, 22525 Hamburg, Germany, Phone: +49-(0)40-56081-286, Fax:+49-(0)40-56081-333, E-mail: investor.relations@evotec.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES